Independent research on the U.S. markets, Baptista Research

Baptista Research

Independent research on the U.S. markets

Baptista Research is an independent financial research house focused on the U.S. markets. We provide equity research as well as credit research reports on the top-listed U.S. companies with most of our focus on technology, consumer goods and services, automobiles, industrials, oil and gas, pharma, and healthcare. Our research has served more than 3000 institutional investors including mutual funds, hedge funds, banks, family offices, and various buy-side firms. We operate a research subscription service where institutions, as well as retail investors, can have priority access to all our research. We also have a wide distribution of our research reports across some of the top global financial platforms. Apart from equity research and credit research, we also provide advisory services with respect to mergers & acquisitions (M&A), private equity/ venture capital fundraising, valuation reports, and investment management services for corporates.
Baptista Research is owned and managed by Ishan Majumdar, an ex-Venture Capitalist/ Investment Banker, a Chartered Accountant, and a Masters’ degree holder in Management from HEC Paris. Ishan has nearly a decade of experience in Mergers and Acquisitions, Leveraged Buyouts (LBOs), Venture Capital Investing, Corporate Strategy, and Valuation in front-office roles at the likes of BNP Paribas CIB, Credit Agricole CIB, Groupe Danone, and TIW Private Equity. He has worked on and closed multiple acquisition deals, leveraged buyouts, and start-up investment transactions.

Equity Bottom-Up

<ul><li>Corteva Agriscience reported a strong first quarter in 2026, with both its Seed and Crop Protection segments delivering double-digit EBITDA growth and over 200 basis points of margin expansion.</li><li>Organic sales increased by 7%, comprised of a 9% rise in Seed and 4% in Crop Protection.</li><li>This performance was supported by a favorable timing shift in North America, an early start to the planting season due to cooperative weather, and volume growth across all regions.</li></ul>

Corteva Agriscience reported a strong first quarter in 2026, with both its Seed and Crop Protection segments delivering double-digit EBITDA growth and over 200 basis points of margin expansion.Organic sales increased by 7%, comprised of a 9% rise in Seed and 4% in Crop Protection.This performance was supported by a favorable timing shift in North America, an early start to the planting season due to cooperative weather, and volume growth across all regions.

Corteva: Why Its Separation Timing Matters MORE Than First Quarter Strength!

<ul><li>Corteva Agriscience's recent earnings update reveals a nuanced picture of the company's performance and future outlook.</li><li>For 2025, Corteva reported sales growth and a notable increase in operating EBITDA, which reflected margin expansion.</li><li>The positive results were driven by strong demand for Corteva's differentiated agricultural technologies, alongside effective cost management strategies in both the Seed and Crop Protection segments.</li></ul>

Corteva Agriscience's recent earnings update reveals a nuanced picture of the company's performance and future outlook.For 2025, Corteva reported sales growth and a notable increase in operating EBITDA, which reflected margin expansion.The positive results were driven by strong demand for Corteva's differentiated agricultural technologies, alongside effective cost management strategies in both the Seed and Crop Protection segments.

Corteva Is Quietly Building a Seed Powerhouse—Here’s What the Market Is Missing!

<ul><li>Corteva Agriscience has reported its performance for the third quarter of 2025, showcasing a blend of strategic realignment and solid financial results.</li><li>The company is planning a strategic separation into two independent public companies by the second half of 2026, dividing its Seed and Crop Protection businesses.</li><li>The rationale behind this move is to enable each unit to optimize their individual growth trajectories amid evolving agricultural market conditions.</li></ul>

Corteva Agriscience has reported its performance for the third quarter of 2025, showcasing a blend of strategic realignment and solid financial results.The company is planning a strategic separation into two independent public companies by the second half of 2026, dividing its Seed and Crop Protection businesses.The rationale behind this move is to enable each unit to optimize their individual growth trajectories amid evolving agricultural market conditions.

Corteva Inside: How a Bold Barter Strategy Is Reinventing Its Power in Latin America!

Founder, CEO, GSBR Research

Garvit Bhandari

Founder, CEO

Leading Provider of Equity and Investment Research

GSBR Research

We are an independent equity research provider focused on covering global markets. The aim of the research is to provide an unbiased view of the fundamentals of the company.

Event-Driven

<ul>
<li>Corteva plans to spin-off its Seeds business in to a separate publicly liated company. Parent will retain the Crop Protection business</li>
<li>The separation enables sharper focus and capital allocation between two fundamentally different businesses.</li>
<li>The seed / trait business is viewed as the higher growth, higher innovation leg (gene editing, trait licensing, intellectual property). These attributes tend to attract premium multiples.</li>
</ul>


Corteva plans to spin-off its Seeds business in to a separate publicly liated company. Parent will retain the Crop Protection business
The separation enables sharper focus and capital allocation between two fundamentally different businesses.
The seed / trait business is viewed as the higher growth, higher innovation leg (gene editing, trait licensing, intellectual property). These attributes tend to attract premium multiples.


Corteva (NYSE: CTVA) To Spin-Off Its Seeds Business; Targets Sharper Focus and Valuation Upside

Founder at Stock Spin-off Investing, Stock Spin-Off Investing

Richard Howe

Founder at Stock Spin-off Investing

Stock Spin-Off Investing

Generate attractive returns by taking advantage of inefficiencies in the stock spin-off market.

Stock Spin-offs

<ul><li>On October 1, 2025, Corteva Biosciences (CTVA) announced that it plans to break up into two public companies.</li><li>The logic behind the spin-off announcement is that the SpinCo has higher margins and better growth potential.</li><li><p>For example, the SpinCo has grown EBITDA at a 16% CAGR since 2020 and has a 26% EBITDA margin.</p><figure class="editor-figure mceNonEditable"></figure></li></ul>

On October 1, 2025, Corteva Biosciences (CTVA) announced that it plans to break up into two public companies.The logic behind the spin-off announcement is that the SpinCo has higher margins and better growth potential.For example, the SpinCo has grown EBITDA at a 16% CAGR since 2020 and has a 26% EBITDA margin.

Weekly Update (CTVA, SFGI/8729, UNTC, MEDXF, IDT)

United States

Corteva, Inc. provides agricultural products. The Company offers seeds and crop protection products, as well as software solutions and digital services. Corteva serves customers worldwide.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Corteva (CTVA US)

Corteva: Why Its Separation Timing Matters MORE Than First Quarter Strength!

Corteva Agriscience reported a strong first quarter in 2026, with both its Seed and Crop Protection segments delivering double-digit EBITDA growth...

Baptista Research

Corteva Is Quietly Building a Seed Powerhouse—Here’s What the Market Is Missing!

Corteva Agriscience's recent earnings update reveals a nuanced picture of the company's performance and future outlook. For 2025, Corteva reported...

Baptista Research

Corteva Inside: How a Bold Barter Strategy Is Reinventing Its Power in Latin America!

Corteva Agriscience has reported its performance for the third quarter of 2025, showcasing a blend of strategic realignment and solid financial...

Baptista Research

Corteva (NYSE: CTVA) To Spin-Off Its Seeds Business; Targets Sharper Focus and Valuation Upside

Corteva to spin-off Seeds business into a separate publicly listed company while retaining Crop Protection business. The separation is expected to...

GSBR Research

Weekly Update (CTVA, SFGI/8729, UNTC, MEDXF, IDT)

On October 1, 2025, Corteva Biosciences (CTVA) announced that it plans to break up into two public companies. The logic behind the spin-off...

Richard Howe

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)

Corteva: Why Its Separation Timing Matters MORE Than First Quarter Strength!

Corteva Agriscience reported a strong first quarter in 2026, with both its Seed and Crop Protection segments delivering double-digit EBITDA growth...

Baptista Research

Corteva Is Quietly Building a Seed Powerhouse—Here’s What the Market Is Missing!

Corteva Agriscience's recent earnings update reveals a nuanced picture of the company's performance and future outlook. For 2025, Corteva reported...

Baptista Research

Corteva Inside: How a Bold Barter Strategy Is Reinventing Its Power in Latin America!

Corteva Agriscience has reported its performance for the third quarter of 2025, showcasing a blend of strategic realignment and solid financial...

Baptista Research

Corteva (NYSE: CTVA) To Spin-Off Its Seeds Business; Targets Sharper Focus and Valuation Upside

​Corteva to spin-off Seeds business into a separate publicly listed company while retaining Crop Protection business. The separation is expected to...

GSBR Research

Weekly Update (CTVA, SFGI/8729, UNTC, MEDXF, IDT)

On October 1, 2025, Corteva Biosciences (CTVA) announced that it plans to break up into two public companies. The logic behind the spin-off...

Richard Howe

Corteva to spin-off Seeds business into a separate publicly listed company while retaining Crop Protection business. The separation is expected to...